Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.38 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | THRA | P10827 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13227693 | 0.98 | KMT2A (0.45) | KMT2AMEN1MDM2ADAMTS5NPC1 | |
| SCHEMBL13379273 | 0.91 | KMT2A (0.42) | KMT2AMEN1MDM2ADAMTS5NPC1 | |
| SCHEMBL14450381 | 0.90 | KMT2A (0.46) | KMT2AMEN1MDM2ADAMTS5NPC1 | |
| SCHEMBL14007040 | 0.90 | KMT2A (0.51) | KMT2AMEN1MDM2ADAMTS5NPC1 | |
| SCHEMBL29368397 | 0.89 | KMT2A (0.45) | KMT2AMEN1MDM2NPC1RAB9A | |
| SCHEMBL29470540 | 0.89 | KMT2A (0.45) | KMT2AMEN1MDM2NPC1RAB9A | |
| SCHEMBL1745934 | 0.89 | KMT2A (0.45) | KMT2AMEN1MDM2NPC1RAB9A | |
| SCHEMBL31146900 | 0.89 | KMT2A (0.45) | KMT2AMEN1MDM2NPC1RAB9A | |
| SCHEMBL3367289 | 0.89 | KMT2A (0.45) | KMT2AMEN1MDM2NPC1RAB9A | |
| SCHEMBL1000962 | 0.89 | KMT2A (0.45) | KMT2AMEN1MDM2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190864-A1 | PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS AND USES THEREOF | 3-D MATRIX, LTD. (JP) | 2023-06-22 | — | — | US | disclosed |
| US-9919065-B2 | Somatostatin analogs with inhibitory activity to growth hormone release | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-03-20 | — | — | US | disclosed |
| US-20160317607-A1 | Purified Amphiphilic Peptide Compositions and Uses Thereof | 3-D MATRIX, LTD. (JP) | 2016-11-03 | — | — | US | disclosed |
| US-20160213793-A1 | SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-07-28 | — | — | US | disclosed |
| US-9200054-B2 | Somatostatin analogs with inhibitory activity to growth hormone release | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-12-01 | — | — | US | disclosed |
| US-20140179598-A1 | SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-06-26 | — | — | US | disclosed |
| US-20130281547-A1 | Purified Amphiphilic Peptide Compositions and Uses Thereof | 3D MATRIX, INC. | 2013-10-24 | — | — | US | disclosed |
| US-8562948-B2 | Somatostatin analogs with inhibitory activity to growth hormone release | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-10-22 | — | — | US | disclosed |
| US-20110243845-A1 | SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-10-06 | — | — | US | disclosed |
| US-7968080-B2 | Somatostatin analogs with inhibitory activity to growth hormone release | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-06-28 | — | — | US | disclosed |
| US-20070041902-A1 | Somatostatin analogs with inhibitory activity to growth hormone release | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160213793-A1 | SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE | GHRHR, GHSR, SSTR4 | KMT2A 4611/4885MEN1 117/4885MDM2 1958/4885 |
| US-20070041902-A1 | Somatostatin analogs with inhibitory activity to growth hormone release | GHRHR, GHSR, SSTR4 | KMT2A 4611/4885MEN1 117/4885MDM2 1958/4885 |
| US-20230190864-A1 | PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS AND USES THEREOF | IAPP, NGLY1, VIP | KMT2A 4520/4885MEN1 935/4885MDM2 276/4885 |
| US-20140179598-A1 | SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE | GHRHR, GHSR, SSTR4 | KMT2A 4611/4885MEN1 117/4885MDM2 1958/4885 |
| US-20110243845-A1 | SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE | GHRHR, GHSR, SSTR4 | KMT2A 4611/4885MEN1 117/4885MDM2 1958/4885 |
| US-20160317607-A1 | Purified Amphiphilic Peptide Compositions and Uses Thereof | IAPP, NGLY1, VIP | KMT2A 4520/4885MEN1 935/4885MDM2 276/4885 |
| US-20130281547-A1 | Purified Amphiphilic Peptide Compositions and Uses Thereof | IAPP, NGLY1, VIP | KMT2A 4520/4885MEN1 935/4885MDM2 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.